Atherogenic Mechanisms of Electronic Nicotine Delivery Systems
电子尼古丁输送系统的致动脉粥样硬化机制
基本信息
- 批准号:10317034
- 负责人:
- 金额:$ 71.91万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-01-01 至 2023-12-31
- 项目状态:已结题
- 来源:
- 关键词:AcetaldehydeAcroleinAerosolsAffectAldehydesAnimal ModelAnimalsApoptosisArterial Fatty StreakAtherosclerosisBlood VesselsCardiovascular DiseasesCarnosineCellsCessation of lifeCharacteristicsChemicalsChronicChronic DiseaseCigarCollagenDataDevicesDipeptidesDiseaseDoseElectronic Nicotine Delivery SystemsElectronic cigaretteEmerging Tobacco ProductsEndotheliumExcisionExposure toFatty acid glycerol estersFormaldehydeGlycerolHumanIn VitroInflammationInflammatoryJUULKnockout MiceLesionLifeLow Density Lipoprotein ReceptorMacrophage ActivationMatrix MetalloproteinasesMeasuresMediatingMicroRNAsMolecularMusMyeloid CellsMyocardial InfarctionNatureNecrosisNicotineNitrosaminesOralPathway interactionsPersonsPlayProcessPropylene GlycolsProteinsRiskRoleSignal TransductionSmokeSmokeless TobaccoSmokerSmokingSmooth Muscle MyocytesStrokeSupplementationTestingThromboplastinTimeTobaccoTobacco smokeTobacco useToxic effectToxinTreesUntranslated RNAUrineVegetablesadductair filteralpha-bungarotoxin receptoratherogenesisatherosclerosis riskbasechronic inflammatory diseasecigarette smokecigarette smokingcigarilloscombustible cigarettecombustion productcytokineelectronic hookahelectronic liquidfeedingheart disease riskhookahinsightmacrophagemortality risknoveloverexpressionprematurepreventrecruitresponsesextobacco productstoxicantvegetable glycerin
项目摘要
Nicotine is an abundant toxicant in various tobacco products including cigarette smoke,
smokeless tobacco, cigars, cigarillos, and hookah. The use of tobacco products increase the risk
for atherosclerosis. Although usage of conventional cigarette has steadily declined over the last
three decades, usage of new and emerging tobacco products and electronic nicotine delivery
systems (ENDS) such as electronic cigarettes (e-cig), e-hookah, and e-cigars has increased
exponentially. ENDS aerosolize a solution known as an “e-liquid” (typically a combination of
propylene glycol, PG, and vegetable glycerol, VG) that contains a small percentage of nicotine.
Although several combustion products and toxins such as CO and tobacco-specific nitrosamines
are non-detectable in ENDS, carbonyls including short-chain toxic aldehydes (acrolein,
formaldehyde, acetaldehyde, etc.) have been detected in e-cig-derived aerosols up to levels
found in tobacco smoke. Our preliminary data suggest that exposure to e-cig or its components,
such as acrolein and nicotine (oral exposure) induce macrophage activation (cytokine formation,
MMP activation, and apoptosis) and exacerbate atherosclerosis. Conversely, quenching of
endogenous aldehydes by feeding with the endogenous dipeptide - carnosine (β-ala-his) or
overexpressing carnosine synthase in macrophages prevents atherosclerosis. Our preliminary
studies also show that chronic exposure to e-cig, nicotine, and acrolein increase the expression
of micro RNA-21 (miR-21) in the aortae of atherogenic mice; and acrolein and nicotine induce
miR-21 in macrophages in culture, presumable as an adaptive response to macrophage
activation. Based on these observations we hypothesize that miR-21 decreases ENDS-induced
atherogenesis by preventing macrophage activation by ENDS-derived aldehydes and nicotine.
To test this hypothesis, we will 1) Examine the effect of e-cig on atherogenesis. In LDL receptor-
null mice exposed to filtered air, varying proportions of propylene glycol (PG):vegetable glycerin
(VG), PG:VG + nicotine, and JUUL-specific e-liquids, we will quantify the time-, dose-, and sex-
dependent changes in atherosclerotic lesion formation. We will examine how ENDS and their
components affect the plaque composition, the nature, and the stability; 2) Delineate the
atherogenic contribution of ENDS-derived aldehydes. We will examine whether quenching of e-
liquid and ENDS-derived aldehydes by oral feeding with carnosine or macrophage-specific
overexpression of carnosine synthase prevents macrophage activation and atherogenesis and
how are these processes regulated by miR-21; 3) Elucidate the atherogenicity of ENDSderived
nicotine. We will probe how ENDS activate macrophage α7nAChR, and how macrophage-specific
deficiency of α7nAChR affects ENDS-induced macrophage activation and atherogenesis. We will
also examine how miR-21 regulates these processes. Overall, the proposed studies will establish
novel animal models of ENDS-induced atherosclerosis, and delineate the underling chemical,
cellular, and molecular mechanisms of toxicity.
尼古丁是多种烟草制品中含有的大量有毒物质,包括香烟烟雾,
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sanjay Srivastava其他文献
Sanjay Srivastava的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sanjay Srivastava', 18)}}的其他基金
Atherogenic Mechanisms of Electronic Nicotine Delivery Systems
电子尼古丁输送系统的致动脉粥样硬化机制
- 批准号:
10533743 - 财政年份:2020
- 资助金额:
$ 71.91万 - 项目类别:
Atherogenic Mechanisms of Electronic Nicotine Delivery Systems
电子尼古丁输送系统的致动脉粥样硬化机制
- 批准号:
9917380 - 财政年份:2020
- 资助金额:
$ 71.91万 - 项目类别:
Atherogenic Mechanisms of Electronic Nicotine Delivery Systems
电子尼古丁输送系统的致动脉粥样硬化机制
- 批准号:
10082463 - 财政年份:2020
- 资助金额:
$ 71.91万 - 项目类别:
Project 2 - Molecular and Cellular Mechanisms of Cardiometabolic Toxicity of VOCs
项目2——VOCs心脏代谢毒性的分子和细胞机制
- 批准号:
10693804 - 财政年份:2017
- 资助金额:
$ 71.91万 - 项目类别:
Environmental Exposure and Cardiometabolic Disease
环境暴露与心血管代谢疾病
- 批准号:
10354688 - 财政年份:2017
- 资助金额:
$ 71.91万 - 项目类别:
KC Donnelly Externship–Promotion of Translational/Transdisciplinary Efforts in Graduate & Post-Doctoral Research
KC Donnelly 实习 — 促进研究生的转化/跨学科努力
- 批准号:
10382018 - 财政年份:2017
- 资助金额:
$ 71.91万 - 项目类别:
Environmental Exposure and Cardiometabolic Disease
环境暴露与心血管代谢疾病
- 批准号:
9904675 - 财政年份:2017
- 资助金额:
$ 71.91万 - 项目类别:
相似国自然基金
Acrolein调控耳蜗核神经元-胶质细胞网络参与感音神经性耳聋发病机制的研究
- 批准号:81570922
- 批准年份:2015
- 资助金额:65.0 万元
- 项目类别:面上项目
acrolein在脊髓损伤后慢性疼痛发生发展中的作用及机制研究
- 批准号:81171052
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
相似海外基金
In vivo anti cancer natural product synthesis based on reaction with endogenous acrolein
基于与内源性丙烯醛反应的体内抗癌天然产物合成
- 批准号:
23KJ0944 - 财政年份:2023
- 资助金额:
$ 71.91万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Prodrug Strategy by Diels-Alder Reaction with Cancer-Derived Acrolein
通过与癌症衍生的丙烯醛进行第尔斯-阿尔德反应的前药策略
- 批准号:
23K17971 - 财政年份:2023
- 资助金额:
$ 71.91万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Reactivity of acrolein produced by cancer cells: Application to selective cancer therapy
癌细胞产生的丙烯醛的反应性:在选择性癌症治疗中的应用
- 批准号:
21K05269 - 财政年份:2021
- 资助金额:
$ 71.91万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Resarch on prevention of cyclophosphamide cardiotocity by removing acrolein
去除丙烯醛预防环磷酰胺强心死亡的研究
- 批准号:
20K08232 - 财政年份:2020
- 资助金额:
$ 71.91万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
In vivo Click Reaction of Acrolein: Application to In vivo Synthetic Chemistry and Cancer Imaging
丙烯醛的体内点击反应:在体内合成化学和癌症成像中的应用
- 批准号:
18K14341 - 财政年份:2018
- 资助金额:
$ 71.91万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Glial activation induced by unsaturated aldehyde acrolein in diabetic retinopathy
不饱和醛丙烯醛诱导糖尿病视网膜病变中的胶质细胞活化
- 批准号:
18K09393 - 财政年份:2018
- 资助金额:
$ 71.91万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Mechanism of acrolein generation in diabetic retinopathy
糖尿病视网膜病变中丙烯醛的生成机制
- 批准号:
17K11442 - 财政年份:2017
- 资助金额:
$ 71.91万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of fluorescent probes for acrolein, a product of lipid peroxidation
脂质过氧化产物丙烯醛荧光探针的开发
- 批准号:
17H06580 - 财政年份:2017
- 资助金额:
$ 71.91万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Role of acrolein in the pathogenesis of diabetic retinopathy
丙烯醛在糖尿病视网膜病变发病机制中的作用
- 批准号:
26462657 - 财政年份:2014
- 资助金额:
$ 71.91万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Novel Treatments of Acrolein-induced Cardiotoxicity
丙烯醛引起的心脏毒性的新疗法
- 批准号:
8610016 - 财政年份:2013
- 资助金额:
$ 71.91万 - 项目类别:














{{item.name}}会员




